Kinnate Biopharma Inc. Annual Operating Lease, Payments in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Kinnate Biopharma Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2022 to 2023.
  • Kinnate Biopharma Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $300K.
  • Kinnate Biopharma Inc. annual Operating Lease, Payments for 2023 was $1.2M, a 100% increase from 2022.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.2M +$600K +100% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $600K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.